February 6 - 7, 2020

MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

San Diego, USA
20+
Speakers
100+
Attendees
4
Specialized Sessions
10+
Networking hours

What are the essentials being missed out on? What is the real role of probiotics strains, prebiotics and symbiotic in influencing a health? How do you standardize microbiome analysis?

Witness the major breakthroughs of microbiome, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.

users

Major breakthroughs of microbial research and applications

users

Challenges associated with medicinal data interpretation, investments and regulatory hurdles

users

Detection of non-identified dysbiosis to discover potential research areas with increasing investments in gut and skin microbiome

Join us at Gen-Next Probiotics and Microbiome Congress, 2020 to network with biotech, pharma, academicians and investors to exchange views and observe the most ingenious research and technologies. Understand what’s happening. Witness the amalgamation of study focused on pharmaceutical and medicinal approaches of probiotics and the nutraceutical and consumer approaches along with the role of microbiome in
clinical applications and preventative medicine.

WHAT TO EXPECT
Key Highlights

Microbial Innovations | Gut and Skin Microbiota | Regulatory Issues | Live Probiotic Technology | Strain Identification | Fecal Microbiota & Engineered Microbiome | Commercialization and Marketing

Who should attend?

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:
Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of:
Microbiome discovery | Microbiome science | Microbiology | Human microbiome | Drug discovery | Therapeutics | Immunotherapy | Microbiology | Microbiome therapeutics | Microbiome | Gastroenterology | Immunology | Bioinformatics | Obstetrics | Neonatology | Pediatrics | Nutritionists/dieticians

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
David Kyle

David Kyle

Executive Chairman and CSO
Evolve BioSystems, Inc

David Kyle

Executive Chairman and CSO
Evolve BioSystems, Inc
Masi Rajabi

Masi Rajabi

Director of Microbiology
Nephron Pharmaceuticals

Masi Rajabi

Director of Microbiology
Nephron Pharmaceuticals
Dawn Bowdish

Dawn Bowdish

Assistant Professor
McMaster University

Dawn Bowdish

Assistant Professor
McMaster University
Maya Ivanjesku

Maya Ivanjesku

Chief Scientific Officer
Dakota Biotech

Maya Ivanjesku

Chief Scientific Officer
Dakota Biotech
Bharath Prithiviraj

Bharath Prithiviraj

Senior Scientist
Prime Discoveries

Bharath Prithiviraj

Senior Scientist
Prime Discoveries
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Maya Ivanjesku

Maya Ivanjesku

Chief Scientific Officer
Dakota Biotech

Maya Ivanjesku

Chief Scientific Officer
Dakota Biotech
Bharath Prithiviraj

Bharath Prithiviraj

Senior Scientist
Prime Discoveries

Bharath Prithiviraj

Senior Scientist
Prime Discoveries
Ross Youngs

Ross Youngs

CEO & Founder
Biosortia Pharmaceuticals

Ross Youngs

CEO & Founder
Biosortia Pharmaceuticals
Seth Crosby

Seth Crosby

Director, Research Collaborations
Washington University School of Medicine

Seth Crosby

Director, Research Collaborations
Washington University School of Medicine
Elliot Friedman

Elliot Friedman

Senior Research Investigator
University of Pennsylvania

Elliot Friedman

Senior Research Investigator
University of Pennsylvania
Peter Leighton

Peter Leighton

CEO
ProSperity Bioscience

Peter Leighton

CEO
ProSperity Bioscience
Tal Korem

Tal Korem

Assistant Professor
Columbia University

Tal Korem

Assistant Professor
Columbia University
SPONSORS
Sponsors & Exhibitors
example-image

Microbiology International

PARTNERS
Supporting Association
The Microbiology Society

The Microbiology Society

Media Partners
example-image

Medical events guide

example-image

CrowdReviews.com

example-image

SciDoc Publishers

LOCATION
San Diego, USA

Please contact us on events@marketsandmarkets.com to get hotel booking link.

About the Hotel

For any queries regarding the hotel booking please write to us at events@marketsandmarkets.com

Hotel Booking Link

You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

NEWS
Card image cap

Australian biotech giant Microba has made an alliance with Macrogen to develop microbiome research services for the offshore market. An MOU has got signed at the Macrogen Headquarters in Seoul on 14 March 2019 defining all the partnership terms and condition. Through this MOU, Macrogen and Microba will establish a close cooperation system. With this partnership, they will try to penetrate into the microbiome market of Korea and other nations. Read more...

PAST EVENT GALLERY